【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Seasonal Influenza Overview 9
Therapeutics Development 10
Pipeline Products for Seasonal Influenza – Overview 10
Pipeline Products for Seasonal Influenza – Comparative Analysis 11
Seasonal Influenza – Therapeutics under Development by Companies 12
Seasonal Influenza – Therapeutics under Investigation by Universities/Institutes 16
Seasonal Influenza – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Seasonal Influenza – Products under Development by Companies 20
Seasonal Influenza – Products under Investigation by Universities/Institutes 24
Seasonal Influenza – Companies Involved in Therapeutics Development 25
AIMM Therapeutics B.V. 25
AltraVax Inc. 26
AmVac AG 27
Baxter International Inc. 28
Big DNA Ltd. 29
BioDiem Ltd 30
Celltrion, Inc. 31
Cilian AG 32
Codagenix, Inc. 33
ContraFect Corporation 34
Crucell N.V. 35
Eurocine Vaccines AB 36
FluGen, Inc. 37
GlaxoSmithKline plc 38
Hemispherx Biopharma, Inc. 39
Inovio Pharmaceuticals, Inc. 40
Johnson & Johnson 41
Liquidia Technologies, Inc. 42
Medicago Inc. 43
Merck & Co., Inc. 44
Novartis AG 45
Novavax, Inc. 46
OPKO Health, Inc. 47
PeptiVir, Inc. 48
Protein Sciences Corporation 49
TechnoVax, Inc. 50
Theraclone Sciences, Inc. 51
Touchlight Genetics Ltd. 52
TSRL, Inc. 53
Vaxart, Inc. 54
Vaxine Pty Ltd 55
VaxInnate Corporation 56
Vivaldi Biosciences Inc. 57
Zydus Cadila Healthcare Limited 58
Seasonal Influenza – Therapeutics Assessment 59
Assessment by Monotherapy Products 59
Assessment by Combination Products 60
Assessment by Target 61
Assessment by Mechanism of Action 63
Assessment by Route of Administration 65
Assessment by Molecule Type 67
Drug Profiles 69
(influenza B virus + influenza A virus [H3N2] + influenza A virus [H1N1]) vaccine – Drug Profile 69
A-06 – Drug Profile 70
Alferon LDO – Drug Profile 71
AMV-401 – Drug Profile 72
BDNA-002 – Drug Profile 73
Bispecific Monoclonal Antibody to Inhibit Hemagglutinin for Seasonal and Pandemic Influenza – Drug Profile 74
CF-404 – Drug Profile 75
CiFlu – Drug Profile 76
CR-8020 – Drug Profile 78
CTP-25 – Drug Profile 80
CTP-27 – Drug Profile 81
FluCell – Drug Profile 82
FVH-1 – Drug Profile 83
IKT-041 – Drug Profile 84
Influ-nRNA – Drug Profile 85
influenza (quadrivalent) vaccine – Drug Profile 86
influenza (split virion, trivalent) vaccine – Drug Profile 88
influenza (trivalent) vaccine – Drug Profile 89
influenza (trivalent) vaccine – Drug Profile 90
influenza (trivalent) vaccine – Drug Profile 91
influenza [A/Christchurch/16/2010 (H1N1) + A/Texas/50/2012 (H3N2) + B/Massachusetts/02/2012 + B/Brisbane/60/2008] (split virion) vaccine – Drug Profile 92
influenza [H1N1] (quadrivalent) virus like particle vaccine – Drug Profile 94
influenza [strain A/H1N1] + [strain A/H3N2] + [strain B] (split virion) vaccine – Drug Profile 96
influenza [strain H1N1] (monovalent) vaccine – Drug Profile 98
influenza vaccine – Drug Profile 100
influenza vaccine – Drug Profile 101
influenza vaccine – Drug Profile 102
influenza vaccine – Drug Profile 104
INO-3510 – Drug Profile 105
LIQ-001 – Drug Profile 106
Monoclonal Antibodies to Inhibit Hemagglutinin for Seasonal Influenza and Pandemic Influenza – Drug Profile 107
NB-1008 – Drug Profile 108
PVI-1000 – Drug Profile 109
respiratory syncytical virus + influenza vaccine – Drug Profile 110
seasonal influenza (quadrivalent) vaccine – Drug Profile 111
seasonal influenza (trivalent) vaccine – Drug Profile 112
seasonal influenza (trivalent) vaccine – Drug Profile 115
seasonal influenza [A/H1N1, A/H3N2, B/Yamagata, B/Victoria] (quadrivalent) vaccine – Drug Profile 116
seasonal influenza [B/Yamagata] (monovalent) vaccine – Drug Profile 117
seasonal influenza [H3N2] vaccine – Drug Profile 118
seasonal influenza B vaccine – Drug Profile 119
seasonal influenza vaccine – Drug Profile 120
seasonal influenza vaccine – Drug Profile 121
seasonal influenza vaccine – Drug Profile 122
seasonal influenza vaccine – Drug Profile 123
Small Molecules for Influenza – Drug Profile 124
Small Molecules to Activate Sirtuin for Influenza – Drug Profile 125
TAK-850 – Drug Profile 126
TCN-032 – Drug Profile 127
TSR-026 – Drug Profile 129
TSR-462 – Drug Profile 130
TVX-001 – Drug Profile 131
VAX-2012Q – Drug Profile 132
VB126 LAIV – Drug Profile 133
VH-244 – Drug Profile 134
VX-787 – Drug Profile 136
VXAA-1.1 – Drug Profile 137
Seasonal Influenza – Recent Pipeline Updates 138
Seasonal Influenza – Dormant Projects 153
Seasonal Influenza – Discontinued Products 155
Seasonal Influenza – Product Development Milestones 156
Featured News & Press Releases 156
Appendix 162
Methodology 162
Coverage 162
Secondary Research 162
Primary Research 162
Expert Panel Validation 162
Contact Us 162
Disclaimer 163
【レポート販売概要】
■ タイトル:季節性インフルエンザ(Seasonal Influenza):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Seasonal Influenza - Pipeline Review, H1 2015
■ 発行日:2015年3月19日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6253IDB
■ 調査対象地域:グローバル
- 世界の低温装置(Cryogenics Equipment)市場動向(2012-2016)TechNavio's analysts forecast the Global Cryogenic Equipment market to grow at a CAGR of 8.56 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth in the Major Applications industry. The Global Cryogenic Equipment market has also been witnessing the increasing R&D spending by vendors. However, the high dependency on limited key supp …
- RTB(リアルタイム入札による広告取引)の世界市場About RTB Market Real-time bidding (RTB) involves the real-time buying and selling of online advertising (ad) display inventory (audience) through a bidding process. This process allows advertisers to bid for the online inventory that best fits their buyer profile. Real-time audience data including location, age, gender, among others. The auction environment is provided by advertising exchanges/ma …
- 親水コロイドの世界市場:ゼラチン、キサンタンガム、カラゲナン、アルギン酸、寒天、ペクチン、グアーガム、ローカストビーンガム、CMC等Hydrocolloids have significant applications in bakery, confectionery, meat & poultry, sauces & dressings, beverage, dairy products, baby foods, and prepared foods. In the food industry, hydrocolloids are used as emulsifiers, stabilizers, gelling agents, coating materials, and gelling agents to enhance the shelf life and texture of the product. The rising demand for healthy food products and preser …
- 過敏性腸症候群(Irritable Bowel Syndrome)治療薬の世界市場予測および分析PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve …
- 軽航空機システムの世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Aerostat Systems Market 2019-2023 Technavio recognizes the following companies as the key players in the global aerostat systems market: Alphabet Inc., DRONE Aviation Holding Corp., Lockheed Martin Corporation, Raytheon Company, RT LTA Systems Ltd., TCOM, L.P.. Commenting on the report, an analyst from Technavio’s team said: “The …
- グローバルコーヒー市場(~2019)The industry report Global Coffee Market to 2019 offers the most up-to-date market data on the actual market situation, and future outlook for coffee in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for k …
- 自動車アクスル(車軸)・プロペラシャフトの世界市場予測(~2021年)The global automotive axle and propeller market size, in terms of value, is estimated to be USD 39.11 Billion in 2016, and is projected to grow to USD 58.07 Billion by 2021, at a CAGR of 8.22%. Growing global vehicle production, and commercialization of new technologies towards light weighting overall vehicle are expected to drive the axle and propeller shaft market. The live axle segment is set t …
- 液体生検の世界市場分析:用途別(転移性乳がん(MBS)の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング)、サンプル別(血液、尿、組織および唾液)、バイオマーカー別(循環腫瘍細胞(CTC)、循環腫瘍DNA(ctDNA)、エキソソーム)、技術別(単一遺伝子解析(PCRマイクロアレイ)、多遺伝子並列分析(NGS))、動向分析、2013-2030Global liquid biopsies market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant challenges associated with conventional biopsies such as, high level of invasiveness, incompleteness of cancer information that is acquired, associated post-biopsy serious medical complicati …
- 肺炎球菌性髄膜炎(Pneumococcal Meningitis):世界の治験レビュー2014年下半期版Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Pneumococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pneumococcal Meningitis. It includes an overview of the trial numbers …
- Hyperinsulinemia:治療薬のグローバル治験動向(2014年上半期)Hyperinsulinemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hyperinsulinemia Global Clinical Trials Review, H1, 2014" provides data on the Hyperinsulinemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperinsulinemia. It includes an overview of the trial numbers and their recruitment statu …
- リスク分析の世界市場予測(~2024年)“Increasing level of complexity across business processes, and rising digitalization & business process automation is expected to drive the overall growth of risk analytics market”The risk analytics market size is expected to grow from USD 23.0 billion in 2019 to USD 45.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.8% during the forecast period. The risk analytics market is driv …
- 世界の性行為感染症(STD)検査市場About this ReportThis report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market se …
- レディミックスコンクリートバッチ処理プラントの世界市場:種類別、地域別Global Ready Mix Concrete Batching Plant Market: About this market Technavio’s ready mix concrete batching plant market analysis considers sales from dry batch concrete plant and wet batch concrete plant types. Our study also finds the sales of ready mix concrete batching plants in APAC, Europe, MEA, North America, and South America. In 2019, the dry batch concrete plant segment had a significant …
- ブレンド型eラーニングの世界市場:eラーニングサービス、コンテンツAbout Blended E-learning Blended learning combines traditional face-to-face interaction with WBL. This mode of learning is prevalent in the K-12 segment. To meet with the evolving needs of students and academicians, regulators in the education industry worldwide are emphasizing on this education methodology than traditional learning methods. Blended learning has made knowledge delivery more produc …
- アメリカのナースコールシステム市場2016-2020About Nurse Call System Market in the USThe NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patie …